Grifols Doubles Factor VIII, IX Treatment Donations to WFH Aid Program

Grifols Doubles Factor VIII, IX Treatment Donations to WFH Aid Program

292158

Grifols Doubles Factor VIII, IX Treatment Donations to WFH Aid Program

Grifols is expanding its commitment to the World Federation of Hemophilia (WFH) Humanitarian Aid Program, donating at least 240 million international units (IU) of blood clotting factors over eight years to consistently treat some 3,000 bleeding disorder patients in developing countries. The contribution, starting in 2022 and running through 2030, more than doubles the company’s donations of plasma-derived factor VIII and factor IX  medicines to the WFH program since 2014. These additional 240 million IUs will “secure…

You must be logged in to read/download the full post.